GLAXOSMITHKLINE PLC

GSK

Delayed - 10/21 11:35:27 am
1410.8GBX	+0.26%

Turn to zoom

Prev.	1407.2000
Open	1410.0000
High	1414.0000
Low	1401.7500
Volume	5 270 230

20h ago	GlaxoSmithKline : Says CDC Panel Voted to Recommend Approval of Shingles...
1d ago	GlaxoSmithKline : Shingles Vaccine Receives Recommendation in US for...
1d ago	GlaxoSmithKline : US Centers for Disease Control and Prevention's Advisory...
1d ago	GlaxoSmithKline : Viom, GlaxoSmithKline Expand Collaboration Into New...

	Short Term	Mid-Term	Long Term
Trend	Neutral	Neutral	Bullish
Resistance	1 429	1 526	1 515
Spread/Res.	-1,3%	-7,5%	-6,9%
Spread/Supp.	2,2%	6,1%	5,0%
Support	1 380	1 330	1 344

Sales 2021	33 519 M 46 242 M 46 242 M
Net income 2021	3 787 M 5 224 M 5 224 M
Net Debt 2021	21 074 M 29 073 M 29 073 M
P/E ratio 2021	18,5x
Yield 2021	5,67%

Capitalization	70 610 M 97 491 M 97 413 M
EV / Sales 2021	2,74x
EV / Sales 2022	2,56x
Nbr of Employees	94 066
Free-Float	92,3%

GlaxoSmithKline PLC is a global healthcare company. The Company operates through two segments: Pharmaceuticals and Vaccines. The Company focuses on its research across six areas: Respiratory diseases, human immunodeficiency virus (HIV)/infectious diseases, Vaccines, Immuno-inflammation, Oncology...

>> Read more

Sector :

Other Pharmaceuticals

Calendar :

2021-10-27 Earnings Release

Trading Rating :

Investor Rating :

Sell Buy
Mean consensus	OUTPERFORM
Number of Analysts	26
Last Close Price	1 410,80 GBX
Average target price	1 602,73 GBX
Spread / Average Target	13,6%